
Investigators have discovered the mechanisms underlying a T-cell receptor’s immunosuppressive function, findings that may improve the development of precision therapeutics for chronic disease, including cancer.

Most non-hospitalized COVID-19 “long-haulers” at the Northwestern Medicine Neuro COVID-19 Clinic continued to experience symptoms including brain fog, dizziness and fatigue 15 months after disease onset, according to a new study.

A blood-based tumor biomarker can predict the benefit of immunotherapy to patients with non-small cell lung cancer.

Northwestern Medicine investigators have discovered a potential therapeutic target for the most common type of pancreatic cancer, according to a study published in Developmental Cell.

Rohail Memon, a second-year medical student, used his finance background to investigate the rise of private equity ownership in dermatology practice.

A new study has identified a drug that inhibits growth of aggressive meningiomas and how to most accurately identify which tumors will respond to the drug.

Northwestern Medicine investigators have identified a gene that confers resistance to a common prostate cancer treatment, according to a study published in Cancer Research.

A Northwestern Medicine study published in Nature Immunology has discovered that mitochondria control the activation of a specific protein complex linked to inflammation and the progression of chronic diseases.

Northwestern and the American Lung Association have begun a first-of-its-kind longitudinal study to track and analyze the lungs of millennials at the peak of their lung health.

A transcription factor associated with androgen receptor activity in prostate cancer has a newly discovered role in controlling lipid biosynthesis.